Patent · US Active

Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin D metabolite

US9746483B2 · kind B2 · utility

0Cited by

3References

2Claims

0Family size

Assignee

DIASOURCE IMMUNOASSAYS S.A. · BE

Inventors

Michel Anciaux · Nalinnes, BE
Fabienne Mathieu · Nivelles, BE
Frederic Lin · Bousval, BE
Martin Poncelet · Louvain-la-Neuve, BE

Key dates

Filing date	May 11, 2015
Grant date	Aug 29, 2017
Priority date	—
Expiry date	Nov 3, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/203332
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention concerns a process for the production of a hybridoma, and of a monoclonal antibody or fragments thereof able to recognize 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.